Closing Stock Market SummaryThe S&P 500 (+0.4%) and Nasdaq Composite (+0.8%) rose to fresh record highs on Tuesday, as the market found continued support in the mega-caps following a disappointing consumer confidence report. The Russell 2000 increased 0.2%, while the Dow Jones Industrial Average declined 0.2%.
Six of the 11 S&P 500 sectors closed higher, while five closed lower. The communication services (+1.0%), health care (+0.7%), information technology (+0.5%), and consumer discretionary (+0.5%) sectors outperformed the benchmark index, while the energy (-1.4%) and utilities (-0.9%) sectors declined the most.
Value-oriented cyclical stocks briefly outperformed growth stocks in a continuation trade from yesterday, but this trade was quickly reversed after the Conference Board's Consumer Confidence Index dropped to 84.8 in August (Briefing.com consensus 93.0) from 91.7 in July for its lowest reading since May 2014.
Presumably, there were some concerns that the decline in consumer confidence would translate to less consumer spending, absent another round of fiscal stimulus. In addition, the report overshadowed new home sales surging 13.9% m/m in July to a seasonally adjusted annual rate of 901,000 (Briefing.com consensus 787,000).
Shares of mega-cap companies like Amazon (AMZN 3346.49, +39.03, +1.2%), Facebook (FB 280.82, +9.43, +3.5%), and Alphabet (GOOG 1608.22, +20.02, +1.3%), which have performed well throughout the pandemic, posted strong gains after a slow start. Apple (AAPL 499.30, -4.13, -0.8%) was a notable exception.
In key stock news, Salesforce (CRM 216.05, +7.59, +3.6%), Amgen (AMGN 248.22, +12.65, +5.4%), and Honeywell (HON 164.53, +5.16, +3.2%) will replace Exxon Mobil (XOM 40.89, -1.33, -3.2%), Pfizer (PFE 38.41, -0.43, -1.1%), and Raytheon Technologies (RTX 60.95, -0.93, -1.5%) in the Dow 30 index prior to the open on Aug. 31.
The new entrants into the Dow saw nice gains, while those leaving declined noticeably. Note, the change was enacted to account for Apple's 4:1 stock split, as its lower price would reduce the price-weighted Dow's exposure to the technology sector.
U.S. Treasuries finished the session mostly lower, with longer-dated maturities seeing a bulk of the losses. The 2-yr yield increased one basis point to 0.16%, and the 10-yr yield increased four basis points to 0.68%. The U.S. Dollar Index declined 0.3% to 93.01. WTI crude futures rose 1.7%, or $0.72, to $43.33/bbl.
Reviewing Tuesday's economic data:
- The Conference Board's Consumer Confidence Index declined to 84.8 in August (consensus 93.0) from a downwardly revised 91.7 (from 92.6) in July. The August reading was the lowest reading for the index since May 2014.
- The key takeaway from the report is the understanding that consumers' assessment of current conditions and the short-term outlook retrenched, reflecting most likely the real economic impact of the expiration of enhanced unemployment benefits and difficult labor market conditions that will weigh on discretionary spending activity.
- New home sales surged 13.9% m/m in July to a seasonally adjusted annual rate of 901,000 (consensus 787,000). That was the strongest pace of sales since December 2006 and noticeably higher than the pre-pandemic pace of 774,000 seen in January.
- The S&P Case-Shiller Home Price Index for June increased 3.5% (consensus 3.6%) following a revised 3.6% increase in May (from +3.7%).
- The FHFA Housing Price Index for August increased 0.9% following a revised 0.2% decline (from -0.3%).
Looking ahead, investors will receive Durable Goods Orders for July and the weekly MBA Mortgage Applications Index on Wednesday.
- Nasdaq Composite +27.8% YTD
- S&P 500 +6.6% YTD
- Dow Jones Industrial Average -1.0% YTD
- Russell 2000 -5.8% YTD
After Hours Summary: CRM +13.4%, URBN +12.7%, INTU +6.1% up big on earnings; PSTG -11.2%, ADSK -2.6% weak on earningsAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: CRM +13.4%, URBN +12.7%, INTU +6.1%, HPE +5.5%, OOMA +4.3%, TOL +2.3%
Companies trading higher in after hours in reaction to news: BKU +11.8% (to join S&P SmallCap 600), TRUP +9.9% (to join S&P SmallCap 600), OII +6.9% (announces contract with Dynetics), WDAY +3% (in sympathy with strong earnings report from CRM), RDFN +1.2% (publishes positive industry report on website), CSCO +0.1% (to acquire privately held BabbleLabs), CNR +0.1% (stock offering), FHI +0.1% (expands distribution in Latin America), ADSW +0.1% (shareholders approve revised terms of WM's acquisition offer)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: PSTG -11.2%, ADSK -2.6%, JWN -2.4%, HEI -2.2%
Companies trading lower in after hours in reaction to news: LRN -4.9% (convertible notes offering), TEVA -4.1% (US business has been indicted on price fixing charges, according to WSJ), LAD -3.4% (to join S&P MidCap 400), SMCI -3.2% (announces settlement with SEC fully resolving previously disclosed investigation), SIBN -1.9% (Medica publishes iFuse coverage policy), CCL -1.4% (cancels two cruises), CDAY -1.3% (stock offering), BBBY -1.1% (announces major realignment of organizational structure, includes 2,800 job cuts), ING -0.1% (files for $12 bln mixed securities shelf offering)
In reaction to earnings/guidance:
- POR -9.7%, PLCE -6.4%, BBY -2.9%, PANW -2.4% (also to acquire The Crypsis Group)
Other news:
- VNET -2.8% (launches 17 mln ADS follow-on offering)
- RTX -1.8% (will be removed from Dow 30 Index on Aug 31)
- XOM -1.3% (will be removed from Dow 30 Index on Aug 31)
- PFE -1.2% (will be removed from Dow 30 Index on Aug 31)
- AHH -0.5% (provides August rent collection update)
Analyst comments:
- GLPG -3.3% (downgraded to Hold from Buy at Jefferies)
- NPTN -2.8% (downgraded to Underperform from Mkt Perform at Raymond James)
- NTR -0.8% (downgraded to Neutral from Overweight at Atlantic Equities)
- ODFL -0.6% (downgraded to Sell from Hold at Stifel)
In reaction to earnings/guidance:
- SJM +4%, MDT +2.8%, SXI +2.7%, HAIN +2.5%, BMO +1.1%, ATHM +1%
Other news:
- OVID +24.8% (Ovid Therapeutics and Takeda (TAK) announced positive topline results from the Phase 2 ELEKTRA study of soticlestat in children with Dravet syndrome or Lennox-Gastaut syndrome)
- MREO +9% (initiates Phase 1b/2 placebo-controlled clinical trial to evaluate the safety and efficacy of alvelestat in hospitalized, adult patients with moderate to severe COVID-19 respiratory disease)
- ALT +8.9% (announced additional results from the preclinical studies of its single-dose intranasal COVID-19 vaccine candidate, AdCOVID)
- CAAS +8.2% (approved a share repurchase program of up to $5 million of its outstanding common shares periodically over the next 12 months)
- AMGN +4.2% (will join Dow 30 Index on Aug 31)
- HON +3.7% (will join Dow 30 Index on Aug 31)
- ALSN +3.3% (begins Vehicle Environmental Test services at Indianapolis facility)
- CRM +2.8% (will join Dow 30 Index on Aug 31)
- AGTC +1.9% (announced that preclinical data on transgene that is being evaluated in its Phase 1/2 clinical trial)
- STRO +1.5% (achieved a clinical supply milestone under its collaboration and license agreement with the healthcare division of Merck KGaA)
- PZZA +1.2% (preliminary estimated comparable sales information for the August fiscal period)
Analyst comments:
- GPS +5.3% (upgraded to Buy from Neutral at Citigroup)
- MERC +4% (upgraded to Sector Outperform from Neutral at CIBC)
- CROX +2.9% (upgraded to Buy from Neutral at B. Riley FBR)
- LB +2.6% (upgraded to Buy from Neutral at MKM Partners)
- ARGX +1.6% (initiated with an Outperform at Raymond James)
- SBUX +1.4% (upgraded to Buy from Hold at Stifel)
- XLRN +1.4% (initiated with a Strong Buy at Raymond James)
- ACAD +1.2% (initiated with an Outperform at Raymond James)
- NXPI +0.7% (initiated with an Overweight at Wells Fargo)
- NIO +0.5% (upgraded to Neutral from Sell at UBS)